Anirudh Sharma

So, my first question is that you mentioned that PHPO continued to be the key growth driver during the quarter. Could you share whether this was largely volume-led or customer additions or better realizations? Also, are you seeing stronger demand from pharma or personal care customers?

So, my question was you mentioned that PHPO continues to be the key growth driver during the quarter. Could you share whether this was largely volume-led or customer additions or better realizations? Also, are you seeing stronger demand from pharma or personal care customers?

Okay. And my second question was export contribution has increased quite significantly this quarter. Should we expect exports to remain around the 50% mark going forward? Or was this elevated due to certain temporary opportunities?